Meta-Analysis of Catheter Ablation as First-Line Therapy for Paroxysmal Atrial Fibrillation

被引：1
|
作者：
Kheiri, Babikir [1 ]
Nazer, Babak [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2022年 / 162卷
关键词：
RADIOFREQUENCY ABLATION; ANTIARRHYTHMIC-DRUGS;
D O I：
10.1016/j.amjcard.2021.09.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：199 / 200
页数：2
相关论文
共 50 条
  • [31] SAFETY AND EFFICACY OF RADIOFREQUENCY ABLATION VS. MEDICAL THERAPY AS FIRST-LINE TREATMENT FOR PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Johnson, Drew M.
    Ullah, Waqas
    Dikdan, Sean J.
    Frankel, Eitan
    Humayun, Wajahat
    Pavri, Behzad B.
    Frisch, Daniel R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 124 - 124
  • [32] Comparison of catheter ablation for paroxysmal atrial fibrillation between cryoballoon and radiofrequency: a meta-analysis
    Chao-feng Chen
    Xiao-fei Gao
    Xu Duan
    Bin Chen
    Xiao-hua Liu
    Yi-zhou Xu
    Journal of Interventional Cardiac Electrophysiology, 2017, 48 : 351 - 366
  • [33] Antiarrhythmic drug therapy and catheter ablation in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis
    Chander, Subhash
    Kumari, Roopa
    Luhana, Sindhu
    Shiwlani, Sheena
    Parkash, Om
    Sorath, Fnu
    Wang, Hong Yu
    Tan, Sam
    Rahaman, Zubair
    Mohammed, Yaqub Nadeem
    Lohana, Abhi Chand
    Sakshi, Fnu
    Vaish, Esha
    Sadarat, Fnu
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
  • [34] Cryoballoon Catheter Ablation versus Antiarrhythmic Drug as a First-Line Therapy for Patients With Paroxysmal Atrial Fibrillation: Results of the Cryo-FIRST Study
    Velagic, Vedran
    Pavlovic, NIkola
    Chierchia, Gian-Battista
    Hermida, Jean-Sylvain
    Healey, Stewart
    Arena, Giuseppe
    Badenco, Nicolas
    Meyer, Christian
    Chen, Jian
    Iacopino, Saverio
    Anselme, Frederic
    Kuniss, Malte
    CIRCULATION, 2020, 142
  • [35] Medical therapy, radiofrequency ablation or cryoballoon ablation as first-line treatment for paroxysmal atrial fibrillation: interpreting efficacy through restricted mean survival time and network meta-analysis
    Messori, Andrea
    Bartoli, Laura
    Ferracane, Elisa
    Trippoli, Sabrina
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2021, 22 (03) : 557 - 561
  • [36] Quality of Life Measured in First-line Therapy for Paroxysmal Atrial Fibrillation: A Comparison Between Cryoballoon Catheter Ablation versus Antiarrhythmic Drug Therapy
    Pavlovic, NIkola
    Kuniss, Malte
    Velagic, Vedran
    Hermida, Jean-Sylvain
    Healey, Stewart
    Arena, Giuseppe
    Badenco, Nicolas
    Meyer, Christian
    Chen, Jian
    Iacopino, Saverio
    Anselme, Frederic
    Chierchia, Gian-Battista
    CIRCULATION, 2020, 142
  • [37] Catheter Ablation as First-Line Therapy in Persistent Atrial Fibrillation Patient Characteristics and Clinical Outcomes
    Barkagan, Michael
    Milman, Anat
    Zahavi, Guy
    Younis, Arwa
    Dhakal, Bishnu
    Dixit, Sanjay
    Wong, Christopher X.
    Gerstenfeld, Edward P.
    Narayan, Sanjiv M.
    Bunch, Jared T.
    Cerbin, Lukasz
    Tzou, Wendy S.
    Metzl, Mark
    Khanani, Aqeel
    Siddiqui, Usman R.
    Mohanty, Sanghamitra
    Natale, Andrea
    Medina, Aaron
    Anter, Elad
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2024, 10 (06) : 1078 - 1086
  • [38] Catheter Ablation as First-Line Therapy in the Treatment of Atrial Fibrillation - Should We Always Indicate it?
    Montenegro Camanho, Luiz Eduardo
    dos Santos, Gustavo Vignoli
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2022, 119 (01) : 95 - 96
  • [39] Catheter ablation of atrial fibrillation as first-line therapy-a single-centre experience
    Tanner, Hildegard
    Makowski, Karol
    Roten, Laurent
    Seiler, Jens
    Schwick, Nicola
    Mueller, Christian
    Fuhrer, Juerg
    Delacretaz, Etienne
    EUROPACE, 2011, 13 (05): : 646 - 653
  • [40] Should cryoballoon ablation of paroxysmal atrial fibrillation be proposed as a first-line treatment?
    Alexis Hermida
    Jean-Sylvain Hermida
    Journal of Interventional Cardiac Electrophysiology, 2022, 65 : 267 - 270
12345